Search research articles
Contact Us
Filters
Showing results (201-210 of 513) with videos related to
Page
of 52
Sort By:
Japanese Journal of Clinical Oncology
|
January 21, 2011
EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma
Youngil Koh, Bogun Jang, Yoon Kyung Jeon, et al.
International Journal of Cancer
|
February 27, 2019
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Sun Hye Shin, Hye Yun Park, Yunjoo Im, et al.
European Journal of Endocrinology
|
April 14, 2021
Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience
Jun Park, Hyun Ae Jung, Joon Ho Shim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2022
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
Sehhoon Park, Jae Myoung Noh, Yoon-La Choi, et al.
Annals of Hematology
|
October 11, 2014
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
Miso Kim, Tae Min Kim, Ki Hwan Kim, et al.
The Korean Journal of Internal Medicine
|
February 28, 2014
Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea
Seon Ha Baek, Hyunsuk Kim, Jeonghwan Lee, et al.
Cancer Research and Treatment
|
December 19, 2015
A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer
Se Hoon Lee, Keunchil Park, Cheolwon Suh, et al.
Cancer Research and Treatment
|
February 27, 2015
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh, Se-Hoon Lee, Sae-Won Han, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
Joo-Young Byun, Jinyong Kim, Sehhoon Park, et al.
Annals of Translational Medicine
|
December 14, 2020
Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data
Ji-Yeon Kim, Hyoung-Oh Jeong, Dae Seog Heo, et al.
Page
of 52
Search research articles
Search
Showing results (201-210 of 513) with videos related to
Sort By:
Page
of 52
Japanese Journal of Clinical Oncology
|
January 21, 2011
EGFR gene copy number gain is related to high tumor SUV and frequent relapse after adjuvant chemotherapy in resected lung adenocarcinoma
Youngil Koh, Bogun Jang, Yoon Kyung Jeon, et al.
International Journal of Cancer
|
February 27, 2019
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
Sun Hye Shin, Hye Yun Park, Yunjoo Im, et al.
European Journal of Endocrinology
|
April 14, 2021
Multimodal treatments and outcomes for anaplastic thyroid cancer before and after tyrosine kinase inhibitor therapy: a real-world experience
Jun Park, Hyun Ae Jung, Joon Ho Shim, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2022
Durvalumab with chemoradiotherapy for limited-stage small-cell lung cancer
Sehhoon Park, Jae Myoung Noh, Yoon-La Choi, et al.
Annals of Hematology
|
October 11, 2014
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
Miso Kim, Tae Min Kim, Ki Hwan Kim, et al.
The Korean Journal of Internal Medicine
|
February 28, 2014
Renal adverse effects of sunitinib and its clinical significance: a single-center experience in Korea
Seon Ha Baek, Hyunsuk Kim, Jeonghwan Lee, et al.
Cancer Research and Treatment
|
December 19, 2015
A Multi-Center, Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Cisplatin for Patients with Non-Small Cell Lung Cancer
Se Hoon Lee, Keunchil Park, Cheolwon Suh, et al.
Cancer Research and Treatment
|
February 27, 2015
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh, Se-Hoon Lee, Sae-Won Han, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2025
A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer
Joo-Young Byun, Jinyong Kim, Sehhoon Park, et al.
Annals of Translational Medicine
|
December 14, 2020
Treatment strategy for papillary renal cell carcinoma type 2: a case series of seven patients treated based on next generation sequencing data
Ji-Yeon Kim, Hyoung-Oh Jeong, Dae Seog Heo, et al.
Page
of 52